VHI vs CC

For growth investors, The Chemours Company (CC) is the stronger pick with 0.

4% revenue growth year-over-year, versus -1. 3% for Valhi, Inc. (VHI). Analysts rate The Chemours Company (CC) a "Hold" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, The Chemours Company (CC) delivered a total return of -22.

7%, compared to -46. 5% for Valhi, Inc. (VHI). Over 10 years, the gap is even starker: CC returned +226. 5% versus VHI's -3. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Valhi, Inc.

(VHI) is the lower-risk stock at 1. 06β versus The Chemours Company's 1. 81β — meaning CC is approximately 71% more volatile than VHI relative to the S&P 500. On balance sheet safety, Valhi, Inc. (VHI) carries a lower debt/equity ratio of 45% versus 18% for The Chemours Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), The Chemours Company (CC) is pulling ahead at 0.

4% versus -1. 3% for Valhi, Inc. (VHI). On earnings-per-share growth, the picture is similar: Valhi, Inc. grew EPS -153. 3% year-over-year, compared to -549. 1% for The Chemours Company. Over a 3-year CAGR, VHI leads at -2. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Valhi, Inc.

(VHI) is the more profitable company, earning -2. 8% net margin versus -6. 6% for The Chemours Company — meaning it keeps -2. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VHI leads at -0. 0% versus -0. 1% for CC. At the gross margin level — before operating expenses — CC leads at 15. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Valhi, Inc.

(VHI) trades at 4. 2x forward P/E versus 15. 5x for The Chemours Company — 11. 4x cheaper on a one-year earnings basis.

All stocks in this comparison pay dividends.

The Chemours Company (CC) offers the highest yield at 2. 3%, versus 2. 2% for Valhi, Inc. (VHI).

For long-horizon retirement investors, Valhi, Inc.

(VHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 06), 2. 2% yield). The Chemours Company (CC) carries a higher beta of 1. 81 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VHI: -3. 0%, CC: +226. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.